Microsoft Corporation vs UiPath, Inc. — Stock Comparison
Q·Score Breakdown
8.7
Very Bullish
Overall
7.8
Bullish
Quality
Health
Growth
Valuation
Sentiment
MSFT
Consensus analyst target of $561.93 is 36% above current price.
PATH
Clean balance sheet with low leverage (0.0× debt-to-equity).
⚠ cautious analyst consensus — few Buy ratings.
Analyst Consensus
BUY
Target $561.93 (+35.6%)
52 analysts
HOLD
Target $13.80 (+29.4%)
16 analysts
Fundamentals
MSFT
PATH
24.7×
Trailing P/E
20.5×
21.5×
Forward P/E
11.9×
39.3%
Profit Margin
17.5%
68.3%
Gross Margin
83.2%
34.0%
ROE
14.4%
18.3%
Revenue Growth
13.6%
23.4%
Earnings Growth
105.7%
1.11
Beta
1.02
—
Price / Book
—
$3.08T
Market Cap
$5.6B
$356 – $555
52-Week Range
$9 – $20
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →